OutSee

eye2gene

Eye2Gene develops an AI-powered platform that analyses retinal imaging to accelerate genetic diagnosis of inherited diseases for pharmaceutical companies and eye care professionals.

Motley Bio

This company develops multi-omic sequencing technology for disease detection and drug discovery services for biotechnology and pharmaceutical firms.

Outpace

This biotechnology company develops custom protein-based biological software to create smart cell therapies for patients with cancer and autoimmune diseases.

Healthcare insights platform

This company provides a data analytics platform that integrates genetic information and clinical research to assist pharmaceutical firms in developing precision medicine and treatments.

VUS Genetics

This company develops high-throughput functional assays for drug developers to classify gene variants and improve patient stratification in oncology and rare disease clinical trials.

Outpost

The company develops microbiome models using machine learning to help drug and food research teams predict biological interactions and assess development risks.

QuirieGen

This company develops single-cell multi-omic technologies and AI models for drug discovery and development within the pharmaceutical sector.

ProtOS

This company develops artificial intelligence models to design de-novo proteins for the degradation of undruggable targets for the pharmaceutical and medical biotechnology industries.